Table 4.
Comparison of success rates and complications rates between patients operated in a HV center with and without a dedicated neurosurgical team.
| SUCCESS RATE | DNT % (95% CI) (n:6) | Not DNT % (95% CI) (n:5) | p |
|---|---|---|---|
| Number of patients (n=1212) | 712 | 500 | – |
| PA | 49.7 (48.5-50.9) | 58.0 (57.6-58.3) | <0.01 |
| R-PA (n= 438 vs. 378) | 80.8 (80.0-81.6) | 76.7 (76.0-77.4) | 0.15 |
| SPA (n= 278 vs. 215) | 62.2 (60.9-63.6) | 57.2 (56.3-58.1) | 0.26 |
| R-SPA (n= 228 vs. 181) | 75.9 (74.9-76.6) | 68.0 (66.2-69.7) | 0.07 |
| ACRO (n= 118 vs. 108) | 60.2 (59.3-61.0) | 50.0 (48.3-51.7) | 0.12 |
| R-ACRO (n= 96 vs. 86) | 74.0 (72.9-75.0) | 62.8 (59.5-66.0) | 0.10 |
| CD (n= 110 vs. 74) | 70.9 (67.1-74.7) | 67.6 (63.5-71.6) | 0.63 |
| R- CD (n= 104 vs. 69) | 75.0 (71.8-78.2) | 72.5 (69.2-75.7) | 0.71 |
| PRL (n= 40 vs. 29) | 40.0 (29.2-50.8) | 55.2 (44.5-65.8) | 0.21 |
| R-PRL (n= 20 vs. 22) | 80.0 (74.8-85.2) | 77.5 (60.1-85.3) | 0.72 |
| NSPA (n= 434 vs. 285) | 41.7 (39.4-44.0) | 58.6 (57.4-59.8) | <0.01 |
| R-NSPA (n= 210 vs. 197) | 86.2 (84.5-88.0) | 84.8 (83.9-85.6) | 0.68 |
| COMPLICATIONS RATE | DNT % (95% CI) (n:6) | Not DNT % (95% CI) (n:5) | p |
| PA | 18.5 (17.5-19.5) | 23.0 (21.9-24.1) | 0.06 |
| R-PA (n= 438 vs. 378) | 16.2 (15.3-17.1) | 22.0 (20.5-23.4) | 0.04 |
| SPA (n= 278 vs. 215) | 14.7 (13.5-16.0) | 18.1 (16.5-19.8) | 0.31 |
| R-SPA (n= 228 vs. 181) | 15.9 (14.7-17.1) | 19.8 (17.9-21.8) | 0.41 |
| ACRO (n= 118 vs. 108) | 11.0 (9.4-12.6) | 15.7 (13.5-17.9) | 0.30 |
| R-ACRO (n= 96 vs. 86) | 11.5 (9.5-13.4) | 18.6 (16.0-21.2) | 0.18 |
| CD (n= 110 vs. 74) | 20.9 (16.5-25.3) | 21.6 (19.2-24.0) | 0.91 |
| R- CD (n= 104 vs. 69) | 22.1 (17.5-26.7) | 20.3 (17.9-22.7) | 0.77 |
| PRL (n= 40 vs. 29) | 10.0 (5.3-14.7) | 20.7 (9.7-31.7) | 0.21 |
| R-PRL (n= 20 vs. 22) | 10.0 (2.7-17.3) | 22.7 (7.8-37.6) | 0.41 |
| NSPA (n= 434 vs. 285) | 21.0 (19.4-22.5) | 26.7 (25.1-28.3) | 0.08 |
| R-NSPA (n= 210 vs. 197) | 16.2 (14.9-17.5) | 24.4 (22.2-26.5) | 0.04 |
| Permanent AVPD | 2.7 (2.6-2.8) | 8.4 (7.6-9.2) | <0.01 |
| CSF leak | 2.4 (2.2-2.6) | 3.2 (3.1-3.3) | 0.39 |
| Reintervention | 2.1 (1.9-2.3) | 2.8 (2.6-3.0) | 0.44 |
| Anterior pituitary deficiency | 13.3 (12.4-14.3) | 16.0 (14.8-17.2) | 0.09 |
Data for TSHoma are not shown.
DNT, dedicated neurosurgical team; PA, pituitary adenoma; SPA, secreting pituitary adenoma; ACRO, GH secreting adenomas; CD, Cushing´s disease; PRLoma, prolactin secreting adenoma; TSHoma, TSH secreting adenoma; NSPA, non-secreting pituitary adenoma; R-PA, resectable PA; AVPD, arginine-vassopresin deficiency; CSF, cerebrospinal fluid.